Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized morphine for acute respiratory distress in adult Covid-19 patients
IRCT20211112053042N2Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of morphine in coronavirus disease 2019 (COVID-19) and acute respiratory distress syndrome (ARDS), sponsored by Alborz University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
morphine
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on IRCT20211112053042N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211112053042N2.